<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Genmab A/S

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Genmab A/S

    Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer. Founded in 1999, the company has two approved antibodies, a broad clinical and pre-clinical product pipeline and three proprietary next generation antibody technologies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $1,100,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Jan G. J. van de Winkel, Ph.D.
    • FOUNDED
      1999
    • EMPLOYEES
      251-500
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Gritstone Oncology, Inc.

    Gritstone Oncology, Inc.

    Gritstone Oncology is developing tumor-specific cancer immunotherapies to fight mu...

    Gritstone Oncology is developing tumor-specific...

    Filing Type:    PU
    IVERIC bio, Inc.

    IVERIC bio, Inc.

    IVERIC bio is a gene therapy focused company developing innovative treatments for ...

    IVERIC bio is a gene therapy focused company de...

    Filing Type:    PU
    Bicycle Therapeutics plc

    Bicycle Therapeutics plc

    Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a no...

    Bicycle Therapeutics is a clinical-stage biopha...

    Filing Type:    PU
    SCYNEXIS, Inc.

    SCYNEXIS, Inc.

    SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the li...

    SCYNEXIS, Inc. is a biotechnology company commi...

    Filing Type:    PU
    Adverum Biotechnologies, Inc.

    Adverum Biotechnologies, Inc.

    Adverum is a clinical-stage gene therapy company targeting unmet medical need in o...

    Adverum is a clinical-stage gene therapy compan...

    Filing Type:    PU
    Aeglea BioTherapeutics, Inc.

    Aeglea BioTherapeutics, Inc.

    Aeglea a clinical-stage biotechnology company that engineers next generation human...

    Aeglea a clinical-stage biotechnology company t...

    Filing Type:    PU
    IGM Biosciences, Inc.

    IGM Biosciences, Inc.

    Headquartered in Mountain View, California, IGM Biosciences is a biotechnology com...

    Headquartered in Mountain View, California, IGM...

    Filing Type:    PU
    Immunomedics, Inc.

    Immunomedics, Inc.

    Immunomedics is a clinical-stage biopharmaceutical company developing monoclonal a...

    Immunomedics is a clinical-stage biopharmaceuti...

    Filing Type:    PU
    Unum Therapeutics Inc.

    Unum Therapeutics Inc.

    Unum Therapeutics is a clinical-stage biopharmaceutical company focused on develop...

    Unum Therapeutics is a clinical-stage biopharma...

    Filing Type:    PU
    BioCurity Pharmaceuticals Inc.

    BioCurity Pharmaceuticals Inc.

    BioCurity is a clinical stage biopharmaceutical company with a mission to material...

    BioCurity is a clinical stage biopharmaceutical...

    Amount Raised:    $177,391.00
    Fundraising Status:    EC
    Filing Type:    CF
    Omeros Corporation

    Omeros Corporation

    Omeros is a commercial-stage biopharmaceutical company committed to discovering, d...

    Omeros is a commercial-stage biopharmaceutical ...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.